Further research deciphering transcriptional codes contained in the IL-33 priming responsive enhancers of synergy target genes could provide insights into the mechanisms underlying IL-33 priming for antigen-mediated MC activation and potentially lead to the development of targeted therapies for infection-exacerbation of allergic inflammation. This evidence concerns the gene IL33 and infection.